Does Rallies show JAGX 10-K and 10-Q filings?

Rallies organizes JAGX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is JAGX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for JAGX. It does not provide personalized investment advice.

JAGX (Jaguar Health, Inc.) Stock Analysis - SEC Filings

Jaguar Health, Inc. (JAGX) is a publicly traded Healthcare sector company. As of May 21, 2026, JAGX trades at $3.51 with a market cap of $1.90M and a P/E ratio of -0.16. JAGX moved +0.00% today. Year to date, JAGX is -88.80%; over the trailing twelve months it is -98.02%. Its 52-week range spans $2.53 to $1,121.59. Rallies surfaces JAGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find JAGX SEC filings?

Rallies organizes JAGX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

JAGX Key Metrics

Key financial metrics for JAGX
Metric	Value
Price	$3.51
Market Cap	$1.90M
P/E Ratio	-0.16
EPS	$-22.97
Dividend Yield	0.00%
52-Week High	$1,121.59
52-Week Low	$2.53
Volume	29.76K
Avg Volume	0
Revenue (TTM)	$11.51M
Net Income	$-54.00M
Gross Margin	67.21%

Latest JAGX News

Jaguar Health Q1 Revenue Jumps 816% to $20.3M on $19M License Deal — May 20, 2026
Jaguar Health Expands Neonorm Franchise with Plant-Based, Non-Prescription Canine Gut Health Product — May 4, 2026
Jaguar Health Executes 1-for-35 Reverse Split to Meet Nasdaq’s $1.00 Bid Requirement — Apr 30, 2026
Jaguar’s Canalevia-CA1 Normalizes Dog Chemotherapy Diarrhea in Three Days with 83% Success — Apr 29, 2026
Jaguar Health Granted Nasdaq Extension, Plans 1-for-35 Reverse Stock Split on April 30 — Apr 27, 2026

JAGX Analyst Consensus

JAGX analyst coverage data. Average price target: $0.00.

Common questions about JAGX

Where can I find JAGX SEC filings?: Rallies organizes JAGX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show JAGX 10-K and 10-Q filings?: Rallies organizes JAGX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is JAGX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for JAGX. It does not provide personalized investment advice.